Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_provenance.
- NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_provenance.
- NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_assertion evidence source_evidence_literature NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_provenance.
- NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_assertion SIO_000772 11877595 NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_provenance.
- NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_assertion wasDerivedFrom befree-20150227 NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_provenance.
- NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_assertion wasGeneratedBy ECO_0000203 NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_provenance.